ISSN: 2161-0932
Vanda Salutari Gynecology Oncology Unit, Policlinico Universitario Agostino Gemelli, RomeSpain
Commentary Commentary on Bevacizumab in Ovarian Cancer: Focus on Clinical Data and Future Perspectives Author(s): Vanda Salutari and Giovanni ScambiaVanda Salutari and Giovanni Scambia
PDF